Aleix Prat
Breast Cancer Research Foundation · 1,395 works · 39,376 citations · h-index 93
Top works
- Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
- Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
- Deconstructing the molecular portraits of breast cancer
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
- Immune-related adverse events of checkpoint inhibitors
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031
- Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
- PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
- PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
- 1671MO Provision of palliative care for patients with cancer and SARS-CoV-2 infection
- 進行性乳癌のためのESO-ESMO国際コンセンサスガイドライン第四版(ABC 4)
- A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
- How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?